Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

ScaleUp Boston – Session 3: Bridging Science, Strategy, and IP for Life-Changing Breakthroughs

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

In celebration of World Health Day, Morrison Foerster and Bayer Co.Lab invite you to an insightful discussion on the critical...

In celebration of World Health Day, Morrison Foerster and Bayer Co.Lab invite you to an insightful discussion on the critical role of intellectual property in shaping the future of healthcare and life sciences innovation. As startups navigate the path from discovery to commercialization, protecting breakthrough ideas becomes essential for long-term success.Join us as we explore IP essentials, patent strategy, and common pitfalls in the rapidly evolving biotech and healthtech sectors. Connect with industry experts, network with like-minded entrepreneurs, and learn how to leverage your IP assets to drive meaningful impact in global health.ScaleUp Boston Session 3: Bridging Science, Strategy, and IP for Life-Changing BreakthroughsSpeakers: Nate Vogler and others TBDIn part three of our four-part series for emerging growth companies, we will focus on the IP issues that challenge today’s startup companies poised at the brink of groundbreaking innovation. Understanding and leveraging Intellectual Property (IP) rights is not just an advantage; it’s a necessity for survival and growth. In this session, you will learn from seasoned patent prosecutors and IP strategists. You will also have the opportunity to network with like-minded innovators and explore how to put your company’s IP to work for you.Our panel of experts will cover the most critical IP issues emerging growth companies face including:<ul><li>IP basics</li><li>Trade secrets vs. Patents</li><li>Patentability vs. Freedom to Operate</li><li>Most common IP mistakes for emerging companies</li></ul>Additional programs in the series will include:<ul><li>April 24: Licensing, Collaborations, Commercial Transactions, and Regulatory Essentials with Matt Karlyn and Brigid Bondoc</li></ul>MOFORUMProgram participants are also invited to our annual MoForum event, set to take place on May 7 at The Newbury Hotel Boston. This free, one-day program brings together leading investors, innovators, and strategists from across the life sciences industry to explore the critical business, legal, and regulatory developments transforming the life sciences ecosystem.Prizes will be awarded to companies attending all five sessions!Space for these events is limited. To register your interest, please use the RSVP button and fill out a short form.<hr>

Sign Up

Nathan Vogler is a Partner in the firm’s Patent Group and heads the patent group’s Materials Science and Energy Storage practice. His practice concentrates on domestic and international patent prosecution, IP due diligence, IP counseling, IP portfolio management, and IP litigation support including patent infringement and validity determinations. Nathan has handled matters in all stages of patent prosecution, including new application drafting, office action responses, patent appeals, and continuation and divisional filings. He has drafted and prosecuted patents in various technology areas, including polymer chemistry, composite materials, industrial processing, nanotechnology, catalysts, batteries, magnets, consumer electronics, and software. In addition, Nathan has experience handling reexaminations, reissue applications, and supplemental examinations before the United States Patent and Trademark Office.In addition to his patent prosecution experience, Nathan also has considerable experience in adversarial proceedings before the USPTO including inter partes review proceedings instituted by the America Invents Act. He has experience representing both Petitioners and Patent Owners, and has represented clients in all stages of the proceedings, such as drafting petitions, patent owner responses, expert depositions, and oral hearings before the PTAB.Representative completed post-grant matters include the following:<ul><li>IPR2021-00210, -00211, -00213: Successfully defended patent owner Malvern against three inter partes reviews, resulting in petition denials.</li><li>IPR2017-01312: Successfully defended patent owner HML. The USPTO found all claims patentable in a final written decision.</li><li>IPR2014-01266, -01313: Defended patent owner HML against two inter partes reviews by different parties, resulting in claim survival or petition denial.</li></ul>Nathan received his J.D. with high honors from The George Washington University Law School, where he was elected to the Order of the Coif and was a member of the George Washington Law Review. He received his B.S. in chemical engineering, with a minor in chemistry, summa cum laude from Purdue University. While in law school, Mr. Vogler was a summer associate at Morrison Foerster.Nathan is admitted to practice in Massachusetts, Virginia and District of Columbia and is registered to practice before the USPTO.

ScaleUp Boston – Session 3: Bridging Science, Strategy, and IP for Life-Changing Breakthroughs

03 Apr 2025 5:30 PM - 8:00 PM EDT